European Patent Office has granted Persica’s first patent

London, UK, 03 February 2022 – Persica is delighted to announce that the European Patent Office has granted Persica’s first patent “Antibiotic Formulations for Lower Back Pain – EP3541442” which provides a foundation for our intellectual property.

Persica’s novel antibiotic formulation for intradiscal administration of antibiotic to treat patients with Chronic Lower Back Pain, PP353, is in international Phase 1b clinical trials.